Report - R&D Meeting - ds-pharma.com · 17 Overall Survival in azacitidine failure higher-risk MDS patients DSP-7888 (7 patients): 6.8 to 15.5 month1) Historical data (435 patients): Median

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form